Summary

Summary

Contract Unique IdentifierDO1.SLCNTR.545612 
Contract referencePROMESECAL-2021-00324 
Contract description:Adquisición de Medicamentos para el Programa de Alto Costo 
Goods 
Contract Start:
06/08/2021 12:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End:
31/12/2021 16:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Legally Binding?
 
Contract StateAccepted 

Contracting Company Identification

Contracting Company Identification


Supplier Company Identification

Supplier Company Identification



Object Info

Object Info

DGCP-08-ProcesosExcepcion 
PROMESECAL-CCC-PEEX-2021-0007 
Adquisicion de Medicamentos para el Programa de Alto Costo 
Adquisicion de Medicamentos para el Programa de Alto Costo 
Dirección de planificación y desarrollo  
DOCTORES MALLEN GUERRA, SA_EXT_CP001 
GoodsDominicana 
200,873,150 Dominican Pesos 

Financial & Delivery Conditions

Financial & Delivery Conditions

Delivery optionsTransporte incluido 
Contract Start Date
06/08/2021 14:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End Date
31/12/2021 16:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Almacén del Ministerio de Salud Pública. 

Payment Conditions

Payment Conditions

Payment Method 
Invoice Payment Deadline60 days 

Contract Comments

Contract Comments


 
 
 1 
DO1.PCCNTR.1172837 ContractData Container
 1.1  
-
    
Total sin descuentosValor del descuentoTotal ITBISTotal Otros ImpuestosSubtotalTotal
200,873,150.000.000.000.00209,540,450.00200,873,150.00
    
ReferenciaCódigo UNSPSCCuenta presupuestariaDescripciónCantidadUnidadPrecio unitario estimadoPrecio unitarioImporte moneda orig. s/ITBIS% Desc.Descuento moneda originalMonto Gravado (Obras)% ITBISITBIS Moneda Original% Otros ImpuestosOtros impuestos moneda originalPrecio total estimadoValor del precio de respuesta
    
1
51161708 - Dornasa alfa
2.3.4.1.01Atezolizumab 1200 mg/20 ml vial90UD390,000384,00034,560,000.000.0000.000.0035,100,000.0034,560,000.00
    
2
51161708 - Dornasa alfa
2.3.4.1.01Bevacizumab 400 mg /16 ml vial130UD105,34091,13011,846,900.000.0000.000.0013,694,200.0011,846,900.00
    
3
51161708 - Dornasa alfa
2.3.4.1.01Dornasa Alfa 2.5 mg/2.5 ml ampolla495UD2,3502,3501,163,250.000.0000.000.001,163,250.001,163,250.00
    
4
51161708 - Dornasa alfa
2.3.4.1.01Emicizumab 30mg vial500UD110,000110,00055,000,000.000.0000.000.0055,000,000.0055,000,000.00
    
5
51161708 - Dornasa alfa
2.3.4.1.01Emicizumab 105 mg vial82UD385,000382,00031,324,000.000.0000.000.0031,570,000.0031,324,000.00
    
6
51161708 - Dornasa alfa
2.3.4.1.01Obinutuzumab 1000 mg / 40 ml vial10UD97,50099,800998,000.000.0000.000.00975,000.00998,000.00
    
7
51161708 - Dornasa alfa
2.3.4.1.01Pertuzumab 420 mg / 14 ml vial70UD197,000197,00013,790,000.000.0000.000.0013,790,000.0013,790,000.00
    
8
51161708 - Dornasa alfa
2.3.4.1.01Rituximab 1400 mg 11.7 ml vial6UD120,00086,500519,000.000.0000.000.00720,000.00519,000.00
    
9
51161708 - Dornasa alfa
2.3.4.1.01Trastuzumab 600 mg /5 ml vial210UD73,00061,40012,894,000.000.0000.000.0015,330,000.0012,894,000.00
    
10
51161708 - Dornasa alfa
2.3.4.1.01Tocilizumab 162 mg/ 0.9 ml Jeringa Precargada672UD11,50011,5007,728,000.000.0000.000.007,728,000.007,728,000.00
    
11
51161708 - Dornasa alfa
2.3.4.1.01Tocilizumab 200 mg/ 10 ml vial1,800UD19,15017,25031,050,000.000.0000.000.0034,470,000.0031,050,000.00
 
Contract Document Template

Contract Document Template

DescriptionFile Name
Download
Download
Download
Download

Budget Settings

Budget Settings

Operation
General Source
200,873,150.00 DOP
 DOP
AccountValueAnnual Availability
2.3.4.1.01200,873,150.00  DOP----View
Payment Calendar
IDDescriptionValueMonthYear
1  transferencia200,873,150.00  DOPOctubre2021
Certificate of Appropriation
YearCertificate CodeCertificate VersionCertificate ValueCertificate StateCertificate Link
2021EG1628187246338DWHWi5242200,873,150.00  DOP
2022EG1628187246338DWHWi5242200,873,150.00  DOP